NCT04631172|Completed
Covid-19 Anxiety and Phobia Levels of the Parents
Evaluation of Covid-19 Anxiety and Phobia Levels of the Parents of Pediatric Patients
Loading search results
Evaluation of Covid-19 Anxiety and Phobia Levels of the Parents of Pediatric Patients
Sponsor study identifier
observational
150
1 country
1
Study Start
May 1, 2020
Actual (reported)Primary Completion
September 30, 2020
Actual (reported)Study Completion
October 15, 2020
Actual (reported)A pandemic that originated in the Wuhan region of China in December 2019 was detected as a new type of coronavirus disease called coronavirus 2019 (COVID-19). In the first phase of the outbreak, specialists explained ways to maintain physical health . However, pediatric surgical procedures and anesthesia applications continued during this period. Surgery in pediatric patients is an unpleasant and potentially 'threatening' experience, often followed by preoperative anxiety due to the child's illness, hospitalization, fear of anesthesia - especially the time of anesthesia induction - and the surgery itself . Anesthesia is a stressful procedure for the child and the entire family. Both the COVID-19 pandemic and the surgical procedure are reflected in the symptoms of anxiety, fear or acute stress disorder for children and their families. As the disease spread, investigators started to emphasize the importance of protecting mental health. Identifying factors that contribute to significant preoperative anxiety levels in pediatric patients and their parents can help healthcare professionals choose the most appropriate from a variety of alternative strategies for anxiety control. This study was planned to evaluate the COVID-19 anxiety and phobia levels of the parents of pediatric patients are scheduled to undergo surgery under general anesthesia in Turkey.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
October 15, 2020
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
May 1, 2020
Actual (reported)September 30, 2020
Actual (reported)October 15, 2020
Actual (reported)November 14, 2020
Actual (reported)November 17, 2020
Actual (reported)Coronavirus Anxiety Scale (CAS)
The Coronavirus Anxiety Scale (CAS), which was developed by Lee and validated in Turkish by Evren et al., was used to evaluate the COVID-19 anxiety level. In the validation study, the Cronbach's alpha of the Turkish version of CAS was 0.87. This results of the study showed that the CAS was highly reliable. CAS is a 5-point Likert-type scale. The scale consists of five questions and one dimension. Scoring of the scale is evaluated as 0 = never, 1 = rare, less than a day or two, 2 = a few days, 3 = more than a week, and 4 = almost every day in the last two weeks. The total score ranges from 0 to 20. Lee determined the CAS cut-off score of 9 to distinguish those with dysfunctional anxiety from those without anxiety.
5 months
COVID 19 phobia scale (C19P-S)
COVID 19 phobia scale (C19P-S) is a 20-item, 4-subdimension (psychological, somatic, social and economic) scale in which items are answered in a 5-point response format developed by Arpacı et al. 7 to measure the phobia that may develop against COVID-19. In the validation study, the Cronbach's alpha of the Turkish version of C19P-S was 0.92. In the present study, Cronbach's alpha was 0.94. The results of the study demonstrated that the C19P-S was exceptionally reliable. The scale items are rated between 1 "strongly disagree" and 5, "strongly agree. Sub-dimension scores are obtained by the sum of the points of the answers given to the items belonging to that sub-dimension, while the total C19P-S score is obtained by the total of the subdimension scores, ranging between 20 and 100 points.
5 months
Using two questionnaire completed in face-to-face interviews Participants were asked the Coronavirus Anxiety Scale (CAS), and the COVID-19 Phobia Scale (C19P-S).
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
The parents of pediatric patients who were scheduled to undergo surgery under general anesthesia in Turkey
Selcuk University, School of Medicine
Konya, 42250, Turkey (Türkiye)
Faruk Cicekci
Selcuk University, School of Medicine, Department of Anesthesiology and Intensive Care
150 participants (actual enrollment reported by the registry).
First Submitted
November 14, 2020
First Posted
November 17, 2020
Study Start
May 1, 2020
Actual (reported)The Effect of Therapeutic Play on Pain, Fear, Anxiety and Physiological Parameters and Parents' Satisfaction
Contact the study team to confirm eligibility.
Primary Completion
September 30, 2020
Actual (reported)Study Completion
October 15, 2020
Actual (reported)Last Updated
November 18, 2020
Record last verified: 2020-11
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: